Survival Rate and Prognostic Factors in Turkish Women Patients with Breast Cancer
Abstract
Background: The study aimed to estimate the overall and disease-free survival rates of breast cancer patients and the factors affecting these rates.
Methods: In this retrospective study, data were obtained from 686 patients diagnosed with breast cancer in Sivas Cumhuriyet University Faculty of Medicine Research and Application Hospital Oncology Center between 1988 and 2014. Total population sampling method was used. The survival rates at certain periods were determined by creating a Life Table. By using the Kaplan-Meier Analysis, the mean survival times and rates were determined, and whether the variables had an impact on survival was examined. By applying Cox regression analysis, the effect of prognostic factors that are significant on the survival time of breast cancer patients was examined.
Results: Overall mean survival time was found as 208.4±11.8 months. According to Kaplan-Meier analysis, 1, 5, 10 and 20-years overall survival rates were 96.6 ± 0.07%, 82.3 ± 1.7%, 64.4 ± 3.4% and 49%± 7.4%, respectively. According to Cox regression analysis results, variables that influence overall survival time were found as disease stage, multicentricity status, ECOG (performance status), presence of diabetes, CA15-3 value, neutrophil/lymphocyte ratio. Moreover, variables that had an impact on the disease-free survival time were found as tumor grade, multicentricity, and ECOG.
Conclusion: Many factors other than disease can prolong survival or accelerate death. Considering the findings of this study may be useful in planning the treatment of breast cancer patients have positive affect on overall survival rates.
https://gco.iarc.fr/today/data/factsheets/cancers/20-Breast-fact-sheet.pdf
2. Meshkat M, Baghestani AR, Zayeri F, et al (2020). Survival Rate and Prognostic Factors among Iranian Breast Cancer Patients. Iran J Public Health, 49(2): 341-350.
3. Yoshida M, Shimizu C, Fukutomi T, et al (2011). Prognostic factors in young Japanese women with breast cancer: prognostic value of age at diagnosis. Jpn j clin oncol, 41(2): 180-9.
4. Shen Y, Yang Y, Inoue LY, et al (2005). Role of detection method in predicting breast cancer survival: analysis of random-ized screening trials. J Natl Cancer Inst, 97(16): 1195-203.
5. Seedhom AE, Kamal NN (2011). Factors affecting survival of women diagnosed with breast cancer in El-Minia Governorate, Egypt. Int J Prev Med, 2(3): 131-8.
6. Zhang M, Chen H, Gu J (2016). Analysis of factors affecting endocrine therapy re-sistance in breast cancer. Oncol Lett, 11(1): 379-384.
7. Denkert C, von Minckwitz G, Darb-Esfahani S, et al (2018). Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. Lancet Oncol, 19(1): 40-50.
8. Nadjib Bustan M, Aidid MK, Afrianty Go-bel F (2018). Cox Proportional Hazard Sur-vival Analysis to Inpatient Breast Cancer Cases. Journal of Physics Conference Se-ries, 1028(1): 012230.
9. Rosai J (2011). Rosai and Ackerman's surgical pa-thology e-book. Elsevier Health Sciences.
10. The Global Cancer Observatory (2012).
http://globocan.iarc.fr/old/FactSheets/cancers/breast-new.asp
11. Acil H, Cavdar I (2014). Comparison of quality of life of Turkish breast cancer pa-tients receiving breast conserving surgery or modified radical mastectomy. Asian Pac J Cancer Prev, 15(13): 5377-81.
12. Rahimzadeh M, Pourhoseingholi MA, Ka-vehie B. (2016). Survival rates for breast can-cer in Iranian patients: a meta-analysis. Asian Pac J Cancer Prev, 17(10): 4615–4621..
13. Çakmak GK, Emiroğlu S, Sezer A, et al (2020). Surgical Trends in Breast Cancer in Turkey: An Increase in Breast-Conserving Surgery. JCO Glob Oncol, 6: JGO.
14. Fidaner C, Eser SY, Parkin DM (2001). In-cidence in Izmir in 1993–1994: first results from Izmir Cancer Registry. Eur J Cancer, 37(1): 83-92.
15. International Agency for Research on Can-cer, World Health Organisation . Globocan Fact Sheets-Turkey. The Global Cancer Ob-servatory; 2018. http://gco.iarc.fr/today/data/factsheets/populations/792-turkey-fact-sheets.pdf
16. Elandt-Johnson RC, Johnson NL (1980). Survival models and data analysis (Vol.110). John Wiley & Sons.
17. Machin D, Cheung YB, Parmar M (2006). Survival analysis: a practical approach. John Wiley & Sons.
18. Cox DR (1972). Regression models and life‐tables. Journal of the Royal Statistical Society: Se-ries B (Methodological). 34(2): 187-202.
19. Hosmer Jr DW, Lemeshow S, May S (2011). Applied survival analysis: regression modeling of time-to-eventdata.https://www.wiley.com/en-gb/Applied+Survival+Analysis:+Regression+Modeling+of+Time+to+Event+Data,+2nd+Edition-p-9780471754992
20. Katz MH (1999). Multivariable Analysis: A Practical Guide for Clinicians. https://www.cambridge.org/core/books/multivariable-analy-sis/DBE7816A781AEF53108FD721199B4AC9
Files | ||
Issue | Vol 51 No 2 (2022) | |
Section | Original Article(s) | |
DOI | https://doi.org/10.18502/ijph.v51i2.8690 | |
Keywords | ||
Breast cancer Survival analysis Cox regression Life table Kaplan-Meier |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |